Table 3.

Proposed data abstraction table for eligible studies included in the scoping review of antipsychotic medication prescribing practices in the acute care setting for clinical indications other than primary psychiatric disorders

Data domain	Data categories
Study identifiers: From a peer-reviewed published study	Authors’ names; study title; publication type; publication date; journal, volume, issue and page numbers of publication; and digital object identifier
Study design: Primary original peer-reviewed or non-peer-reviewed observational or interventional research	Study type or design; time frame of study; location of study (ie, country)
Population: Adult acute care patients, family members and healthcare professionals (including physicians, nurses and pharmacists)	Definition and size (ie, N) of the source population(s); relevant demographic information (eg, age, sex, gender); admitting diagnosis, patient hospital length of stay (if applicable)
Exposure: Administration of an antipsychotic medication	Method of recruitment; type of antipsychotic medication administered; inclusion and exclusion criteria; baseline imbalances; duration of study
Outcomes: Antipsychotic prescribing or deprescribing strategies; patient, family and/or healthcare professional centred outcomes	Approaches or strategies used to facilitate antipsychotic prescribing or deprescribing including facilitators and/or barriers; author’s recommendations and conclusions Patient, family and/or healthcare professional-centred outcomes: perceptions and/or experiences related to medication prescribing and deprescribing of antipsychotic medications